Melkersson-Rosenthal syndrome presenting as a new daily persistent headache: Relief with dapsone [3]

Cephalalgia

Volumn 21, Issue 9, 2001, Pages 924-925

  Rozen, T D ^a,b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPSONE; DIHYDROERGOTAMINE; DROPERIDOL; GADOLINIUM; INDOMETACIN; METHYLPREDNISOLONE; PREDNISONE; PROCHLORPERAZINE; STEROID;

ADULT; CASE REPORT; DIABETES MELLITUS; DRUG RESPONSE; FACIAL NERVE PARALYSIS; FEMALE; GRANULOMA; HEADACHE; HUMAN; LETTER; MELKERSSON ROSENTHAL SYNDROME; NAUSEA; PAIN ASSESSMENT; PHOTOPHOBIA; RECURRENT DISEASE; STEROID DIABETES; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DAPSONE; FEMALE; HEADACHE DISORDERS; HUMANS; MELKERSSON-ROSENTHAL SYNDROME;

EID: 0035741534     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2001.00278.x     Document Type: Letter

References (5)

1. Melkersson-Rosenthal syndrome and orofacial granulomatosis
2. The Melkersson-Rosenthal syndrome
3. Melkersson-Rosenthal syndrome: A review of 36 patients
4. Classification of daily and near-daily headaches: Proposed revision to the IHS classification
5. The clinical characteristics of new daily persistent headache